Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.

Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger L, Koenig J, Galle PR.

BMC Cancer. 2016 Aug 31;16:699. doi: 10.1186/s12885-016-2736-9.

2.

Localization of Rab proteins to peroxisomes: a proteomics and immunofluorescence study.

Gronemeyer T, Wiese S, Grinhagens S, Schollenberger L, Satyagraha A, Huber LA, Meyer HE, Warscheid B, Just WW.

FEBS Lett. 2013 Feb 14;587(4):328-38. doi: 10.1016/j.febslet.2012.12.025. Epub 2013 Jan 16.

3.

RhoA regulates peroxisome association to microtubules and the actin cytoskeleton.

Schollenberger L, Gronemeyer T, Huber CM, Lay D, Wiese S, Meyer HE, Warscheid B, Saffrich R, Peränen J, Gorgas K, Just WW.

PLoS One. 2010 Nov 8;5(11):e13886. doi: 10.1371/journal.pone.0013886.

4.

Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling.

Wiese S, Gronemeyer T, Ofman R, Kunze M, Grou CP, Almeida JA, Eisenacher M, Stephan C, Hayen H, Schollenberger L, Korosec T, Waterham HR, Schliebs W, Erdmann R, Berger J, Meyer HE, Just W, Azevedo JE, Wanders RJ, Warscheid B.

Mol Cell Proteomics. 2007 Dec;6(12):2045-57. Epub 2007 Sep 2.

Supplemental Content

Loading ...
Support Center